We are live on ! Find out more
MCM

M28 Capital Management Portfolio holdings

AUM $53.8M
1-Year Est. Return 28.63%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+28.63%
3 Year Est. Return
+218.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$14.6M
Cap. Flow
+$4.17M
Cap. Flow %
3.08%
Top 10 Hldgs %
98.58%
Holding
11
New
1
Increased
–
Reduced
6
Closed
–

Top Buys

Rank Stock Value
1
GUTS icon
Fractyl Health
GUTS
+$15.6M

Top Sells

Rank Stock Value
1
RCKT icon
Rocket Pharmaceuticals
RCKT
+$3.91M
2
PRQR icon
ProQR Therapeutics
PRQR
+$1.91M
3
WVE icon
Wave Life Sciences
WVE
+$1.87M
4
SWTX
SpringWorks Therapeutics
SWTX
+$1.5M
5
SLN
Silence Therapeutics
SLN
+$1.4M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$1.12B
$43.2M 31.91%
7,000,000
-373,413
-5% -$1.87M
IVVD icon
2
Invivyd
IVVD
$180M
$41.1M 30.34%
9,248,250
– –
GUTS icon
3
Fractyl Health
GUTS
$123M
$13.7M 10.15%
+1,856,117
New +$15.6M
RCKT icon
4
Rocket Pharmaceuticals
RCKT
$348M
$10.4M 7.68%
385,680
-137,600
-26% -$3.91M
SLN
5
Silence Therapeutics
SLN
$521M
$6.47M 4.78%
299,400
-64,400
-18% -$1.4M
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
$5.43M 4.02%
110,400
-32,400
-23% -$1.5M
CRIS icon
7
Curis
CRIS
$9.53M
$4.59M 3.39%
21,098
– –
BBIO icon
8
BridgeBio Pharma
BBIO
$16.5B
$3.75M 2.77%
121,200
– –
TGTX icon
9
TG Therapeutics
TGTX
$8.58B
$2.46M 1.82%
161,600
-55,000
-25% -$876K
PRQR icon
10
ProQR Therapeutics
PRQR
$243M
$2.33M 1.73%
1,019,498
-891,102
-47% -$1.91M
ARWR icon
11
Arrowhead Research
ARWR
$12.1B
$1.93M 1.42%
67,400
– –

Similar funds

NCM
Notable Capital Management Menlo Park, California $53.4M AUM 10.98% 1-Year Est. Return
WEO
William E. Oberndorf $53.3M AUM 10.89% 1-Year Est. Return
MML
Mercato Management Legacy Cottonwood Heights, Utah $54.3M AUM
CAM
Copperwood Asset Management Houston, Texas $54.4M AUM
ETCM
Evolutionary Tree Capital Management Alexandria, Virginia $53.2M AUM 13.56% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $54.4M AUM
TP
Toronado Partners San Francisco, California $53M AUM 13.38% 1-Year Est. Return
GMEI
Global Media & Entertainment Investments Nassau, Bahamas $53M AUM 0% 1-Year Est. Return

M28 Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, M28 Capital Management held 11 positions worth $135M, up 12% from $121M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

M28 Capital Management deployed $4.17M of net new capital in Q1 2024, opening 1 new position. Its largest new stake was Fractyl Health: 1,856,117 shares worth $13.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Rocket Pharmaceuticals, an estimated $3.91M trimmed.

  • M28 Capital Management's largest Q1 2024 buy was Fractyl Health: 1,856,117 shares worth $13.7M.
  • M28 Capital Management's biggest Q1 2024 reduction was Rocket Pharmaceuticals, cutting an estimated $3.91M.
  • M28 Capital Management's ten largest holdings make up 99% of its $135M portfolio in Q1 2024.
  • M28 Capital Management opened 1 new position and closed 0 in Q1 2024.
  • M28 Capital Management's portfolio value rose 12% quarter-over-quarter to $135M.

Based on M28 Capital Management's 13F filing for Q1 2024, filed 14 May 2024.